Need Help?

TB-DAR Whole Genome Sequencing Study

116 Whole Genome Sequencing (WGS) samples from the TB-DAR study, based on a cohort of adult pulmonary tuberculosis patients recruited in Dar es Salaam, Tanzania. WGS was performed at the Health2030 Genome Center in Geneva on the Illumina NovaSeq 6000 instrument (Illumina Inc, San Diego CA, USA), starting from1μg of whole blood genomic DNA and using Illumina TruSeq DNA PCR-Free reagents for library preparation and the 150nt paired-end sequencing configuration. Average coverage was above 30X for 75 samples, between 10X and 30Xfor 40 samples, and approximately 8X for a single sample. Sequencing reads were aligned to the GRCh38 (GCA_000001405.15) reference genome using bwa (Version 0.7.17).

Request Access

TB-DAR WGS Policy

Definitions Authorised Personnel: The individuals at the User Institution to whom EPFL-GRFE grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: EPFL-GRFE and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. EPFL-GRFE: Fellay Lab (EPFL-GRFE) EPFL SV GHI GR-FE SV 3824 Station 19 CH-1015 Lausanne 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify EPFL-GRFE within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify EPFL-GRFE prior to any significant changes to the protocol for the Project. 14. The User Institution will notify EPFL-GRFE as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. EPFL-GRFE may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than EPFL-GRFE. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005850 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005729684 cram 51.1 GB
EGAF00005729685 cram 40.9 GB
EGAF00005729686 cram 24.8 GB
EGAF00005729687 cram 20.2 GB
EGAF00005729688 cram 41.1 GB
EGAF00005729689 cram 17.1 GB
EGAF00005729690 cram 68.9 GB
EGAF00005729691 cram 125.7 GB
EGAF00005729692 cram 27.8 GB
EGAF00005729693 cram 48.0 GB
EGAF00005729694 cram 108.0 GB
EGAF00005729695 cram 51.1 GB
EGAF00005729696 cram 54.8 GB
EGAF00005729697 cram 46.9 GB
EGAF00005729698 cram 67.8 GB
EGAF00005729699 cram 27.6 GB
EGAF00005729700 cram 92.4 GB
EGAF00005729701 cram 15.2 GB
EGAF00005729702 cram 55.0 GB
EGAF00005729703 cram 32.3 GB
EGAF00005729704 cram 21.4 GB
EGAF00005729705 cram 21.3 GB
EGAF00005729706 cram 364.2 GB
EGAF00005729707 cram 62.8 GB
EGAF00005729708 cram 58.5 GB
EGAF00005729709 cram 77.2 GB
EGAF00005729710 cram 67.2 GB
EGAF00005729711 cram 61.0 GB
EGAF00005729712 cram 106.8 GB
EGAF00005729713 cram 49.3 GB
EGAF00005729714 cram 71.2 GB
EGAF00005729715 cram 18.2 GB
EGAF00005729716 cram 29.9 GB
EGAF00005729717 cram 69.4 GB
EGAF00005729718 cram 72.4 GB
EGAF00005729719 cram 23.8 GB
EGAF00005729720 cram 82.1 GB
EGAF00005729721 cram 55.1 GB
EGAF00005729722 cram 55.0 GB
EGAF00005729723 cram 23.1 GB
EGAF00005729724 cram 44.2 GB
EGAF00005729725 cram 67.7 GB
EGAF00005729726 cram 17.4 GB
EGAF00005729727 cram 16.7 GB
EGAF00005729728 cram 34.0 GB
EGAF00005729729 cram 34.2 GB
EGAF00005729730 cram 59.5 GB
EGAF00005729731 cram 74.1 GB
EGAF00005729732 cram 47.4 GB
EGAF00005729733 cram 84.2 GB
EGAF00005729734 cram 74.0 GB
EGAF00005729735 cram 56.8 GB
EGAF00005729736 cram 44.3 GB
EGAF00005729737 cram 45.4 GB
EGAF00005729738 cram 66.9 GB
EGAF00005729739 cram 21.7 GB
EGAF00005729740 cram 81.7 GB
EGAF00005729741 cram 19.6 GB
EGAF00005729742 cram 38.3 GB
EGAF00005729743 cram 25.6 GB
EGAF00005729744 cram 32.6 GB
EGAF00005729745 cram 59.5 GB
EGAF00005729746 cram 56.3 GB
EGAF00005729747 cram 85.6 GB
EGAF00005729748 cram 21.3 GB
EGAF00005729749 cram 61.9 GB
EGAF00005729750 cram 48.4 GB
EGAF00005729751 cram 40.6 GB
EGAF00005729752 cram 23.6 GB
EGAF00005729753 cram 53.4 GB
EGAF00005729754 cram 33.2 GB
EGAF00005729755 cram 42.6 GB
EGAF00005729756 cram 90.6 GB
EGAF00005729757 cram 44.8 GB
EGAF00005729758 cram 55.3 GB
EGAF00005729759 cram 96.3 GB
EGAF00005729760 cram 63.0 GB
EGAF00005729761 cram 41.7 GB
EGAF00005729762 cram 81.2 GB
EGAF00005729763 cram 79.3 GB
EGAF00005729764 cram 55.5 GB
EGAF00005729765 cram 18.8 GB
EGAF00005729766 cram 83.2 GB
EGAF00005729767 cram 52.5 GB
EGAF00005729768 cram 37.4 GB
EGAF00005729769 cram 75.1 GB
EGAF00005729770 cram 75.6 GB
EGAF00005729771 cram 55.0 GB
EGAF00005729772 cram 74.1 GB
EGAF00005729773 cram 62.3 GB
EGAF00005729774 cram 11.2 GB
EGAF00005729775 cram 30.0 GB
EGAF00005729776 cram 48.3 GB
EGAF00005729777 cram 63.0 GB
EGAF00005729778 cram 45.7 GB
EGAF00005729779 cram 68.6 GB
EGAF00005729780 cram 21.8 GB
EGAF00005729781 cram 66.0 GB
EGAF00005729782 cram 18.3 GB
EGAF00005729783 cram 64.6 GB
EGAF00005729784 cram 54.7 GB
EGAF00005729785 cram 24.4 GB
EGAF00005729786 cram 28.3 GB
EGAF00005729787 cram 47.4 GB
EGAF00005729788 cram 55.9 GB
EGAF00005729789 cram 62.5 GB
EGAF00005729790 cram 32.7 GB
EGAF00005729791 cram 47.7 GB
EGAF00005729792 cram 87.6 GB
EGAF00005729793 cram 69.6 GB
EGAF00005729794 cram 62.6 GB
EGAF00005729795 cram 36.0 GB
EGAF00005729796 cram 64.3 GB
EGAF00005729797 cram 66.4 GB
EGAF00005729798 cram 64.8 GB
EGAF00005729799 cram 19.9 GB
116 Files (6.3 TB)